UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study

Wolking, S; Schulz, H; Nies, AT; McCormack, M; Schaeffeler, E; Auce, P; Avbersek, A; ... Lerche, H; + view all (2020) Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study. Pharmacogenomics , 21 (5) pp. 325-335. 10.2217/pgs-2019-0179. Green open access

[thumbnail of Article]
Preview
Text (Article)
Figure_1_Wolking.pdf - Accepted Version

Download (299kB) | Preview
[thumbnail of Figure 1]
Preview
Text (Figure 1)
Sander_Manuscript_Wolking_120419.pdf - Accepted Version

Download (1MB) | Preview

Abstract

Aim: Pharmacoresistance is a major burden in epilepsy treatment. We aimed to identify genetic biomarkers in response to specific antiepileptic drugs (AEDs) in genetic generalized epilepsies (GGE). / Materials & methods: We conducted a genome-wide association study (GWAS) of 3.3 million autosomal SNPs in 893 European subjects with GGE – responsive or nonresponsive to lamotrigine, levetiracetam and valproic acid. / Results: Our GWAS of AED response revealed suggestive evidence for association at 29 genomic loci (p <10-5) but no significant association reflecting its limited power. The suggestive associations highlight candidate genes that are implicated in epileptogenesis and neurodevelopment. / Conclusion: This first GWAS of AED response in GGE provides a comprehensive reference of SNP associations for hypothesis-driven candidate gene analyses in upcoming pharmacogenetic studies.

Type: Article
Title: Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.2217/pgs-2019-0179
Publisher version: https://doi.org/10.2217/pgs-2019-0179
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: GWAS, antiepileptic drugs, genetic generalized epilepsy, lamotrigine, levetiracetam, pharmacoresistance, valproic acid
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Experimental Epilepsy
URI: https://discovery.ucl.ac.uk/id/eprint/10096586
Downloads since deposit
282Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item